A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis B

NCT04225715 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

281

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: Nucleos(t)ide (NUC)
DRUG: CpAM (RO7049389)
DRUG: TLR7 (RO7020531)
DRUG: siRNA (RO7445482)
DRUG: PEG-IFN
DRUG: PD-L1 LNA (RO7191863)

Sponsor

Hoffmann-La Roche